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ABSTRACT RNA-remodeling proteins, including RNA helicases and chaperones, act
to remodel RNA structures and/or protein-RNA interactions and are required for all
processes involving RNAs. Although many viruses encode RNA helicases and chaper-
ones, their in vitro activities and their roles in infected cells largely remain elusive.
Noroviruses are a diverse group of positive-strand RNA viruses in the family Caliciviri-
dae and constitute a signiﬁcant and potentially fatal threat to human health. Here,
we report that the protein NS3 encoded by human norovirus has both ATP-
dependent RNA helicase activity that unwinds RNA helices and ATP-independent
RNA-chaperoning activity that can remodel structured RNAs and facilitate strand an-
nealing. Moreover, NS3 can facilitate viral RNA synthesis in vitro by norovirus poly-
merase. NS3 may therefore play an important role in norovirus RNA replication.
Lastly, we demonstrate that the RNA-remodeling activity of NS3 is inhibited by gua-
nidine hydrochloride, an FDA-approved compound, and, more importantly, that it
reduces the replication of the norovirus replicon in cultured human cells. Altogether,
these ﬁndings are the ﬁrst to demonstrate the presence of RNA-remodeling activities
encoded by Caliciviridae and highlight the functional signiﬁcance of NS3 in the no-
roviral life cycle.
IMPORTANCE Noroviruses are a diverse group of positive-strand RNA viruses, which
annually cause hundreds of millions of human infections and over 200,000 deaths
worldwide. For RNA viruses, cellular or virus-encoded RNA helicases and/or chaper-
ones have long been considered to play pivotal roles in viral life cycles. However,
neither RNA helicase nor chaperoning activity has been demonstrated to be associ-
ated with any norovirus-encoded proteins, and it is also unknown whether norovirus
replication requires the participation of any viral or cellular RNA helicases/chaper-
ones. We found that a norovirus protein, NS3, not only has ATP-dependent helicase
activity, but also acts as an ATP-independent RNA chaperone. Also, NS3 can facilitate
in vitro viral RNA synthesis, suggesting the important role of NS3 in norovirus repli-
cation. Moreover, NS3 activities can be inhibited by an FDA-approved compound,
which also suppresses norovirus replicon replication in human cells, raising the pos-
sibility that NS3 could be a target for antinoroviral drug development.
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Noroviruses are a genetically diverse group of nonenveloped, positive-strand RNAviruses belonging to the genus Norovirus of the family Caliciviridae. They are
further segregated into seven genogroups (GI to GVII), three of which (GI, GII, and GIV)
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cause diseases exclusively in humans (1–3). Human noroviruses (HuNoVs) are now
considered the leading cause of viral gastroenteritis in humans across the globe. HuNoV
infections are estimated to cause 684 million cases of diarrheal disease, 1.1 million
hospitalizations, and 212,000 deaths annually worldwide, with an economic burden of
approximately $60 billion per year (4, 5). They are highly contagious, infecting people
of all ages, with higher incidence in young children and low-income settings (4, 5).
Although HuNoV infections are usually acute and self-limiting with low mortality, they
often cause chronic or life-threatening infections and symptoms in immunocompro-
mised patients and the elderly (6). As a result of their high infectivity, stability, and
resistance to common sanitizers, HuNoV has also been classiﬁed as a category B
biodefense agent (6, 7). However, despite its substantial burden and potential threat,
there are still no vaccines or antiviral drugs available to prevent or treat norovirus
infection (4, 5, 8).
The noroviral genomic RNA is 7.4 to 7.7 kb in length and is typically organized into
three open reading frames (ORF1 to -3) (8). Exceptionally, the GV murine norovirus
(MNV) has an additional ORF (ORF4) within ORF2 (9, 10). The 5=-proximal ORF1 encodes
a large polyprotein that is cleaved by a norovirus-encoded protease (NS6Pro) into at
least six mature nonstructural proteins, while the 3=-proximal region of noroviral
genomic RNA is transcribed into a subgenomic RNA that contains ORF2 and ORF3,
which encode the major and minor structural proteins VP1 and VP2, respectively (Fig.
1A). Although these viruses have been extensively studied for decades, our under-
standing of the mechanisms of the nonstructural proteins involved in norovirus repli-
cation is very limited, particularly in comparison to other positive-strand RNA viruses,
such as picornaviruses and ﬂaviviruses.
For many RNA viruses, the viral RNA (vRNA) contains multiple cis-acting elements
that play pivotal roles in vRNA replication, translation, and encapsidation during the
viral life cycle (11–13). As with cellular RNA molecules, these elements are often highly
structured in vRNAs and must be folded into the correct tertiary structures to be
functional. However, this can be problematic, because RNAs can be easily trapped in
stable but misfolded intermediate states (14, 15). To avoid this, cells and viruses encode
a variety of RNA-remodeling proteins, such as RNA helicases and RNA chaperones,
which can destabilize RNA-RNA or RNA-DNA duplexes to promote the proper folding or
refolding of RNAs (16–18). In addition, viral or cellular RNA helicases are thought to
participate in the unwinding of viral replicative-intermediate double-stranded RNAs
(vRI-dsRNAs) formed during vRNA replication, thereby allowing recycling of vRNA
templates for further rounds of vRNA synthesis. RNA helicases have nucleoside triphos-
phatase (NTPase) activity, using the energy of NTP binding and/or hydrolysis to unwind
RNA duplexes, and are believed to participate in most ATP-dependent rearrangement
of structured RNAs (19). RNA chaperones are a heterogeneous group of proteins that
can destabilize RNA duplexes and promote correct RNA folding in an ATP-independent
fashion (20). A wide range of RNA viruses, including ﬂavivirus (21), picornavirus (22),
alphavirus (23), coronavirus (24), reovirus (25), iﬂavirus (26), and alphatetravirus (27),
have been found to encode their own RNA helicases and/or RNA chaperones (28).
Sequence analysis showed that the norovirus NS3 protein, also known as p41,
contains signature motifs that are conserved in superfamily 3 (SF3) viral helicases, such
as the human enterovirus 2CATPase (EV71 2CATPase) (22), simian virus 40 (SV40) large T
antigen (LTag) (29), adeno-associated virus 2 (AAV2) Rep40 (30, 31), and the human
papillomavirus 18 (HPV18) E1 protein (32) (Fig. 1). Consistent with this observation, the
NS3 protein encoded by Southampton virus (SHV), a GI HuNoV, has been shown to
have NTPase activity (33). In addition, norovirus NS3 has been recently reported to
associate with vRI-dsRNAs in a viral replication complex (vRC) and to induce vesicular
structures (34–36). However, previous work has yet to demonstrate RNA helicase or
chaperoning activity associated with NS3 or any other norovirus- or calicivirus-encoded
proteins or that the replication of norovirus or calicivirus requires the participation of
any viral or host RNA-remodeling activities. This gap hampers our understanding of the
replication mechanisms of this large group of medically important human pathogens,
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FIG 1 Norovirus NS3 is similar to other virus-encoded SF3 helicases in consensus motifs and protein structures. (A) The genomic RNA
of norovirus contains three ORFs (ORF1, -2, and -3). The 5=-proximal ORF1 encodes a polyprotein that is subsequently self-cleaved into
six nonstructural proteins (NS1/2, NS3, NS4, NS5/VPg, NS6Pro, and NS7/RdRP) by viral protease NS6Pro. ORF2 and ORF3 encode
structural proteins VP1 and VP2, respectively. (B) Sequence alignment of the helicase core domains of NV NS3 and other SF3 viral
helicases, EV71 2CATPase, SV40 LTag, HPV18 E1, and AAV2 Rep40. The SF3 consensus motifs A, B, and C are indicated. Completely
conserved residues (100% identity) are highlighted in black, and highly conserved residues (50% identity) are highlighted in gray.
(Continued on next page)
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as well as the development of antinoroviral drugs that may speciﬁcally target viral RNA
helicase/chaperoning activities.
Our previous work on enterovirus 2CATPase revealed that, in vitro, 2CATPase has
RNA-remodeling activity when expressed using a baculovirus-based expression system
(22). Here, we show that NS3 encoded by Norwalk virus (NV) (genotype GI.1 HuNoV),
the prototype strain of the genus Norovirus, also has NTP-dependent RNA helicase
activity. Moreover, we demonstrate that NS3 can also act as an RNA chaperone that is
able to remodel structured RNAs and facilitate strand annealing independently of NTP.
We have also found that NS3 can facilitate the in vitro synthesis of vRNA by NV
NS7/RNA-dependent RNA polymerase (RdRP) on the 3= antigenomic template, suggest-
ing that NS3 plays an important role in norovirus RNA replication. Additionally, we have
demonstrated that guanidine hydrochloride (GuHCl), which is a U.S. FDA-approved
small-molecule drug and a well-known inhibitor of poliovirus 2CATPase, is able to inhibit
the RNA helicase activity of NS3 in a dose-dependent manner. More importantly, GuHCl
has been further determined to inhibit the replication of the NV replicon in cultured
human cells, which highlights the functional signiﬁcance of NS3 in the noroviral life
cycle.
RESULTS
NV NS3 (NS3NV) shares similar consensus motifs and structure with other SF3
viral helicases. A comparison of the amino acid sequence of NV NS3 with those of
members of the SF3 viral helicases, including EV71 2CATPase, AAV2 Rep40, SV40 LTag,
and HPV18 E1, revealed that NV NS3 contains the conserved SF3 helicase A, B, and C
motifs (Fig. 1B).
Since the three-dimensional (3D) structure of norovirus NS3 has not yet been
reported, we modeled the NV NS3 structure using the ROBETTA server for protein
structure prediction and analysis (37). The predicted model of NV NS3 revealed that the
C-terminal two-thirds, consisting of amino acids at positions 122 to 363 (i.e., NS3ΔN), is
comprised of two structurally independent domains: a helicase core (HC) (amino acids
[aa] 122 to 288) forming a central ﬁve-stranded -sheet sandwiched by -helices on
both sides, and the C-terminal domain (CTD) (aa 289 to 363) comprising several
-helices. These domains are linked by ﬂexible loops (Fig. 1C) and, interestingly,
demonstrate limited similarity with the counterpart region of EV71 2CATPase (22).
Moreover, the predicted SF3 motifs A, B, and C of NV NS3 nicely overlap the conserved
SF3 motifs in these other SF3 viral helicases (Fig. 1D to F).
NV NS3 contains NTPase activity. Previous studies by Pﬁster and Wimmer found
that bacterially expressed SHV NS3 has NTPase activity (33). To conﬁrm whether NV NS3
also has this activity, we expressed a recombinant maltose binding protein (MBP) fusion
with NV NS3 (MBP-NS3) using a baculovirus expression system and then examined the
NTPase activity by incubating MBP-NS3 with different NTPs. The hydrolysis of NTP was
measured using a sensitive colorimetric assay that determines the total amount of
released inorganic phosphate. As was found for SHV NS3, our data showed that NV NS3
hydrolyzed all four types of NTPs (Fig. 2A). However, although SHV NS3 was reported
to hydrolyze UTP less well than ATP (33), NV NS3 exhibited similar efﬁciency in the
hydrolysis of these NTPs (Fig. 2A).
To further characterize the NTPase activity of NV NS3, we assessed the ATPase
activity of MBP-NS3 under different ATP and Mg2 concentrations, as well as at
different pHs, as ATP is the major energy source in cells. Our results showed that the
amount of hydrolyzed ATP increased with increasing amounts of ATP (Fig. 2B). In
addition, our data indicated that the ATPase activity of MBP-NS3 is Mg2 dependent,
FIG 1 Legend (Continued)
Dashes indicate no amino acid and are included for alignment purposes. (C) The structure of NV NS3 without its N-terminal domain
(NS3ΔN) was predicted by the HMMSTR/Rosetta server. NS3ΔN containing the middle HC domain and the CTD is shown in green. SF3
motifs A, B, and C are indicated and highlighted in red. (D to F) Structural alignments of NV NS3ΔN (green) and SV40 LTag, HPV18E1,
or AAV2 Rep40 (cyan). The N-terminal domain of E2 binding to HPV18 E1 is shown in brown. SF3 motifs A, B, and C of these viral
helicases are highlighted in blue.
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since its ATP-hydrolyzing activity was undetectable in the absence of Mg2. While the
ATPase activity of MBP-NS3 was found to be optimal at a 2 mM Mg2 concentration,
higher levels of Mg2 inhibited the ATPase activity (Fig. 2C). The optimal pH for
MBP-NS3 ATPase activity was found to be 7.6, but broad activity was maintained
between pH 6.8 and pH 8.0 (Fig. 2D).
We also expressed the MBP fusion with NV NS3 using Escherichia coli and examined
its NTPase activity. We conﬁrmed that the MBP-NS3NV expressed by bacteria can also
hydrolyze ATP and other NTPs and shows biochemical properties similar to those of the
MBP-NS3NV expressed by eukaryotes (data not shown). Altogether, our data demon-
strate that, similar to SHV NS3, NV NS3 has NTPase activity that hydrolyzes all four NTPs
and is Mg2 dependent.
NV NS3 has nucleic acid helix-unwinding activity. To assess the potential helix-
unwinding activity of NV NS3, we annealed a short hexachloroﬂuorescein (HEX)-labeled
RNA and a longer unlabeled RNA to generate a standard RNA helix substrate with both
5= and 3= single-strand protrusions (Fig. 3A and Table 1). The helix-unwinding assay was
performed by incubating the standard RNA helix substrate with puriﬁed MBP-NS3 in
the standard unwinding reaction and then evaluating the substrate via gel electropho-
resis. As shown in Fig. 3A, the HEX-labeled RNA strand was released from the RNA helix
substrate in the presence of MBP-NS3, whereas the RNA helix substrate remained
annealed when MBP alone was added as a mock helicase, showing that NV NS3 can
unwind the RNA helix. The reactions were performed in the presence of ATP and MgCl2.
The boiled helix substrate or the addition of an MBP fusion with EV71 2CATPase was used
here and in subsequent experiments as a relevant control for helix-unwinding activity.
Because some viral RNA helicases have been reported to unwind DNA helices or
RNA-DNA hybrids (22), we sought to examine if NV NS3 can unwind nucleic acid helices
containing DNA. For this purpose, we constructed three helix substrates: a DNA duplex
(D*/D) (Fig. 3B) and RNA-DNA hybrids with a longer unlabeled RNA (D*/R) (Fig. 3C) or
FIG 2 NV NS3 has NTPase activity. (A) MBP-NS3 was reacted with the indicated NTPs. The NTPase activity was
measured as nanomoles of released inorganic phosphate. (B to D) The NTPase activity of MBP-NS3 was determined
at the indicated concentrations of ATP (B), at the indicated concentrations of Mg2 (C), or at the indicated pH (D).
(B and C) MBP alone was used as the negative control. (A to D) The error bars represent standard deviation (SD)
values from the results of three separate experiments.
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DNA (R*/D) (Fig. 3D) strand. Each helix substrate was reacted with MBP-NS3 under the
same condition as for Fig. 3A, and our results showed that NV NS3 could efﬁciently
unwind either of the RNA-DNA hybrids (Fig. 3C and D) but unwound the DNA duplexes
less effectively (Fig. 3B).
We further evaluated the RNA helix-unwinding activity of MBP-NS3 under different
conditions. We observed that the helix-unwinding activity of MBP-NS3 can be pro-
moted by the presence of NTP, particularly ATP or GTP (Fig. 4B), indicating that NV NS3
has an RNA helicase activity. Consistent with the characterization of NS3 NTPase activity
(Fig. 2C and D), the optimized helix-unwinding activity of MBP-NS3 was found to be
around 2 mM Mg2 (Fig. 4C) at a pH value of around 7.6 (Fig. 4D). Collectively, these
ﬁndings suggest that NV NS3 has NTP-dependent nucleic acid helix-unwinding activity.
NV NS3 directs RNA helix unwinding from both 5=¡3= and 3=¡5= directions.
The directionality of helix unwinding is a fundamental characteristic of helicases (19).
Previous studies of other SF3 viral helicases have revealed that the helicase activity of
FIG 3 NV NS3 has nucleic acid helix-unwinding activity. (A) The standard RNA/RNA helix (R*/R substrate)
is illustrated in the upper diagram. R*/R substrate (0.1 pmol) was reacted with 20 pmol of each indicated
protein. Nonboiled reaction mixture (lane 1) and reaction mixture with MBP alone (lane 3) were used as
negative controls, and boiled reaction mixture (lane 2) and reaction mixture with puriﬁed MBP fusion
with EV71 2CATPase (lane 5) were used as positive controls. (B to D) DNA/DNA helix (D*/D substrate),
DNA/RNA hybrid helix (D*/R), and RNA/DNA hybrid helix (R*/D) are illustrated in the upper diagrams; 0.1
pmol of each indicated substrate was reacted with 20 pmol of each indicted protein. Lanes 1, nonboiled
reaction mixture; lanes 2, boiled reaction mixture; lanes 3, reaction mixture with puriﬁed MBP-NS3 fusion;
lanes 4, reaction mixture with puriﬁed MBP-EV71 2CATPase fusion. Helix unwinding was detected via gel
electrophoresis and scanning on a Typhoon 9500 imager. The asterisks indicate the HEX-labeled strands.
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EV71 2CATPase has a 3=¡5= directionality, while AAV2 Rep40 and HPV18 E1 unwind
helices bidirectionally (22, 31, 32). To determine the unwinding directionality of NV NS3,
we generated two different RNA helix substrates, one containing a 5= single-strand
protrusion (Fig. 5A) and the other with a 3= single-strand protrusion (Fig. 5B). Each
substrate was subjected to a helix-unwinding assay in the presence of MBP-NS3. Our
data showed that RNA helix substrates with either a 5= or a 3= protrusion could be
unwound by MBP-NS3 (Fig. 5C). Moreover, the unwinding of either substrate by
MBP-NS3 could be promoted by the presence of ATP in a dose-dependent manner (Fig.
5D and E). Based on these observations, we conclude that NV NS3 directs the unwind-
ing of the RNA helix from both 5=¡3= and 3=¡5= directions in an ATP-dependent
manner, similar to AAV2 Rep40, another SF3 viral helicase (22, 31, 32).
The conserved SF3 A motif is critical for the helicase activity of NS3. The
sequence analysis of NS3 indicated that NS3 contains consensus motifs that are
characteristic of SF3 viral helicases (Fig. 1). Motif A has been recognized as a core
element of the NTP binding and NTPase active site of SF3 helicases (19) and is
conserved in different noroviruses (Fig. 6A). Previous work by Pﬁster and Wimmer has
shown that the mutation of motif A in SHV NS3 almost completely eliminated its
ATPase activity (33). Moreover, motif B of SF3 helicases has been reported to chelate
Mg2 (19). We wanted to investigate if the conserved SF3 motif A or B is important for
the helicase activity associated with norovirus NS3. To this end, we generated the
TABLE 1 Oligonucleotides
Oligonucleotide Sequence (5=–3=)a
RNA1 CAUUAUCGGAUAGUGGAACCUAGCUUCGACUAUCGGAUAAUC
RNA2 AAUAAAGAUUAUCCGAUAGUCGAAGCUAGGUUCCACUAUCCGAUAAUGAAAUAA
RNA3 UGUAGUGCUGCCAUGGUGUGGUGGUGGUGGUUGUGGUGGAGCUACGAAC
RNA4 GAUUAUCCGAUAGUCGAAGCUAGGUUCCACUAUCCGAUAAUGAAAUAA
RNA5 AAUAAAGAUUAUCCGAUAGUCGAAGCUAGGUUCCACUAUCCGAUAAUG
DNA1 AATAAAGATTATCCGATAGTCGAAGCTAGGTTCCACTATCCGATAATGAAATAA
DNA2 CACCACAACCACCACCACCACACCATGG
DNA3 TGTAGTGCTGCCATGGTGTGGTGGTGGTGGTTGTGGTGGAGCTACGAAC
Probe GUGAAUGAAGAUGGCGUCUAACGGCGCUUCCGCUGCCGCUGUUGCCAACAGCAACAACGACAUCGCAAAAUCUU
CAAGUGACGGUGUGUUUUCUAACAUGGCUGUCACUUUUAAGCGGGCCCUCGGGGCG CGGCCUAAAC
aHEX-labeled strands are in boldface.
FIG 4 Biochemical characterization of RNA helix-unwinding activity of NV NS3. (A) Illustration of the standard RNA helix (R*/R) substrate.
(B to D) R*/R substrate (0.1 pmol) was reacted with 20 pmol MBP-NS3 in the absence or presence of individual NTP (B), increasing
concentrations of Mg2 (C), or different pH values (D) as indicated. Nonboiled (lanes 1) or boiled (lanes 2) reaction mixture was used as
a negative or positive control. The asterisks indicate the HEX-labeled strands. Helix-unwinding activity was detected by gel electrophoresis
and scanning on a Typhoon 9500 imager.
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GK168AA and GK168AA-DD212AA mutants of the MBP-NS3 fusion (MBP-NS3GK168AA
and MBP-NS3GK168AA-DD212AA) and expressed the proteins using the baculovirus ex-
pression system. In our standard helix-unwinding assays, we found that both the
GK168AA and GK168AA-DD212AA mutations dramatically reduced the helix-unwinding
activity of NS3 compared to the wild type (WT) (Fig. 6B). Moreover, the addition of
increasing concentrations of ATP had very little effect on helix unwinding by MBP-
NS3GK168AA (Fig. 6C). These ﬁndings show that the conserved SF3 motifs are critical for
the helicase activity of NS3.
NV NS3 also possesses NTP-independent RNA-chaperoning activity. Although
we had determined that NV NS3 requires NTP to reach its optimal helix-unwinding
activity (Fig. 4B and 5D and E) and that the conserved SF3 A motif is critical for its
helicase activity (Fig. 6), we found that a portion of the helical RNA substrate could still
be unwound by MBP-NS3 in the absence of ATP (Fig. 4B and 5D and E). To conﬁrm
these observations and exclude the possible interference of trace amounts of NTP in
the unwinding assays, we alternatively used AMP-PNP, an ATP analog that is nonhy-
drolyzable and able to block NTPase activity. The incorporation of 5 mM AMP-PNP
instead of ATP or other NTPs did not completely abolish RNA helix unwinding by
MBP-NS3 (Fig. 7A). While both RNA helicases and RNA chaperones possess RNA-
remodeling activities, the fundamental difference between them is that the former
activity requires the participation of NTP whereas the latter is NTP independent (20).
These observations, therefore, suggest that NV NS3 also contains NTP-independent
RNA-chaperoning activity.
RNA chaperones are generally thought to destabilize misfolded RNA secondary
structures to facilitate the re-formation of more stable RNA structures (15). To further
characterize the RNA-chaperoning activity of NV NS3, we adapted a canonical assay
that evaluates the helix-destabilizing and annealing acceleration activities of RNA
chaperones (38). In this assay, we designed and generated two 42-nucleotide (nt) cRNA
strands, each of which forms a deﬁned stem-loop secondary structure; in addition, one
FIG 5 NV NS3 unwinds the RNA helix in a bidirectional manner. (A and B) Schematic illustration of the RNA helix substrate with the 5= single-strand
protrusion (A) or 3= single-strand protrusion (B). The asterisks indicate the HEX-labeled strands. (C) MBP-NS3 (20 pmol) was incubated with 5=
single-strand protruded (lane 3) or 3= single-strand protruded (lane 6) RNA helix substrate (0.1 pmol). Nonboiled (lanes 1 and 4) or boiled (lanes
2 and 5) reaction mixtures were used as negative or positive controls. (D and E) MBP-NS3 (20 pmol) was reacted with 5=-protruded (D) or
3=-protruded (E) RNA helix substrate in the presence of the indicated concentrations of ATP. Helix unwinding was detected as described for
Fig. 3.
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strand is 5= HEX labeled and the other is unlabeled, as indicated in Fig. 7B. Equal
amounts of the two strands were mixed and incubated in the presence or absence of
MBP-NS3, and the hybridization of the two strands was then determined using a gel
shift assay. In these reactions, ATP or other NTPs were not supplemented. Our data
showed that the levels of the annealed hybrids gradually increased with the increasing
amounts of MBP-NS3 (Fig. 7C). Moreover, although minimal spontaneous hybridization
could be observed in the absence of MBP-NS3 with prolonged incubation times (Fig.
7D, lanes 3 to 6), the addition of MBP-NS3 further enhanced the hybridization at each
time point (Fig. 7D, lanes 7 to 10). Altogether, our results show that NV NS3 can
destabilize structured RNAs and facilitate the formation of a more stable RNA structure,
conﬁrming that NV NS3 is also an NTP-independent RNA chaperone.
NV NS3 promotes noroviral RNA synthesis in vitro. For positive-strand RNA
viruses, their RdRP-mediated vRNA replication generates viral replicative-intermediate
double-stranded RNAs that could be unwound by RNA helicases in order to recycle
vRNA templates (39). Virus-encoded RNA chaperones may help rearrange the struc-
tured RNA elements of vRNA templates, thereby facilitating vRNA synthesis (25). After
determining the RNA helicase and chaperoning activities of NV NS3, we wanted to
evaluate the potential role of NS3 in norovirus RNA replication. As illustrated in Fig. 8A,
we incubated a recombinantly puriﬁed MBP fusion with HuNoV NS7/RdRP protein with
FIG 6 SF3 motif A is critical for the helicase activity of NV NS3. (A) Amino acid sequence alignment of NV NS3, SHV NS3, and MNV NS3.
The SF3 consensus motifs A, B, and C are indicated. Completely conserved residues (100% identity) are highlighted in black. (B) The
standard RNA helix (R*/R) substrate (0.1 pmol) was reacted with 20 pmol WT (lane 4), GK168AA (lane 5), or GK168AA-DD212AA (lane 6)
MBP-NS3. Nonboiled reaction mixture (lane 1) and reaction mixture with addition of MBP alone (lane 3) were used as negative controls;
the boiled reaction mixture (lane 2) was used as a positive control. (C) The standard RNA helix (R*/R) substrate (0.1 pmol) was reacted with
20 pmol GK168AA mutant MBP-NS3 in the presence of the indicated concentrations of ATP. (B and C) The asterisks indicate the
HEX-labeled strands.
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in vitro-transcribed RNA corresponding to the 400 nt at the 3= end of HuNoV antige-
nomic ()-vRNA, which is presumably the template for the initiation of ()-vRNA
synthesis, in the presence or absence of WT or GK168AA mutant MBP-NS3. The reaction
mixture was not supplemented with an oligonucleotide RNA primer, as noroviral RNA
synthesis can occur primer independently, at least in vitro (40). The newly synthesized
RNA was detected by Northern blotting using a probe speciﬁc for ()-vRNA. Here, we
observed that the presence of WT MBP-NS3 promoted the NS7/RdRP-mediated pro-
duction of ()-vRNA strands from the ()-vRNA templates and that the promoting
effect of NS3 could be further enhanced by increasing the reaction time (Fig. 8B and C).
On the other hand, the A motif mutation mostly eliminated the promoting effect of
MBP-NS3 on in vitro RNA synthesis (Fig. 8D and E).
GuHCl inhibits the NTPase and RNA helix-unwinding activities of NV NS3.
Previous studies have reported that the NTPase and RNA helicase activities of entero-
virus 2CATPase can be inhibited by GuHCl (22, 41–45), which also inhibits replication of
the vRNAs of a number of enteroviruses (46, 47). Given the similarity between the
consensus motifs in enterovirus 2CATPase and norovirus NS3, we wanted to examine
whether NV NS3 could also be a target for guanidine inhibition. NTPase assays showed
FIG 7 NV NS3 has RNA-chaperoning activity to destabilize structured RNA strands and promote annealing.
(A) The standard RNA helix (R*/R) substrate (0.1 pmol) was reacted with 20 pmol MBP-NS3 in the absence
or presence of 5 mM ATP or ATP analog (AMP-PNP) as indicated. Lane 1, nonboiled reaction mixture; lane
2, boiled reaction mixture; lane 3, reaction mixture with MBP-NS3 in the absence of ATP; lanes 4 and 5,
reaction mixture with MBP-NS3 in the presence of AMP-PNP or ATP. (B) Schematic illustrations of the
stem-loop structures of the two complementary 42-nt RNA strands. The asterisk indicates the HEX-labeled
strand. (C) The two strands were mixed 1:1 (0.1 pmol each) and reacted with the indicated amounts of
MBP-NS3. (D) The hybridization assay (as for panel C) was conducted in the absence (lanes 3 to 6) or
presence (lanes 7 to 10) of 20 pmol MBP-NS3 for the indicated reaction times. (C and D) The preannealed
(lanes 1) or boiled (lanes 2) strands were used as a positive or negative control, respectively. The hybridized
and free strands are indicated.
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that GuHCl inhibited the ATPase activity of NV NS3 in a dose-dependent manner
(Fig. 9A). This result is in contrast to a previous observation by Pﬁster and Wimmer, who
demonstrated that even in the presence of up to 10 mM GuHCl, the ATPase activity of
SHV NS3 was not inhibited (33). These contrasting results might be due to the different
expression strategies (eukaryotic versus prokaryotic) or the inherent biochemical prop-
erties of the two NS3 proteins, which were also shown to have different hydrolysis
preferences for UTP (Fig. 2A) and different responses to Mg2 concentrations higher
than 2 mM (Fig. 2C).
To examine if GuHCl could also inhibit helix unwinding by NV NS3, the helix-
unwinding reactions were performed in the presence of NS3 and increasing concen-
trations of GuHCl. Our results showed that the presence of GuHCl inhibited helix
unwinding by NS3 in a dose-dependent manner (Fig. 9B and C). Intriguingly, we
examined the effect of GuHCl on the RNA-chaperoning activity of NV NS3 using an RNA
strand hybridization assay. Our data showed that the addition of GuHCl at different
concentrations had no obvious effect on NS3 RNA-chaperoning activity (Fig. 9D).
It is important to note that the helicase activity and ATPase activity show similar
sensitivities to GuHCl and that the inhibitory effects of GuHCl on helicase and ATPase
FIG 8 NV NS3 facilitates noroviral RNA synthesis in vitro. (A) Schematic illustration of the experimental procedures. (B and D) The in
vitro-transcribed NV 3= end (nt 1 to 400) of ()-vRNA template was incubated with 10 pmol recombinant NS7/RdRP and NTP mixture in
the absence or presence of 10 pmol MBP-NS3 (B) or MBP-NS3GK168AA (D) at 30°C for 30, 60, or 90 min as indicated. The reaction products
were detected by Northern blotting. (C and E) The synthesized ()-RNA products in panels B and D were quantiﬁed with Bio-Rad Quantity
One software. The relative RNA production was determined by comparing the level of RNA products in the presence of MBP-NS3 at each
indicated time point with that in the absence of NS3 at 30 min (lanes 2). The error bars represent SD values from the results of three
separate experiments.
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FIG 9 GuHCl inhibits the biochemical activities of NV NS3. (A) The NTPase activity of MBP-NS3 was measured as nanomoles of released inorganic
phosphate in the presence of the indicated concentrations (0 to 10 mM) of GuHCl. MBP alone was used as the negative control. (B) The standard
RNA helix (R*/R) substrate is illustrated in the upper diagram. R*/R substrate (0.1 pmol) was reacted with 20 pmol MBP-NS3 in the presence of
the indicated concentrations (0 to 10 mM) of GuHCl. Native (lane 1) or boiled (lane 2) reaction mixture was used as a negative or positive control,
respectively. Helix unwinding was detected by gel electrophoresis and scanning on a Typhoon 9500 imager. The asterisk indicates the
HEX-labeled strand. (C) The unwinding activities under different GuHCl concentrations were plotted as percentages of the released RNA from the
total RNA helix substrate (y axis) at each indicated GuHCl concentration (x axis) with Bio-Rad Quantity One software. The error bars represent
standard deviation values from the results of three separate experiments. (D) The two strands shown in Fig. 7B were mixed 1:1 (0.1 pmol each)
and reacted with 10 pmol MBP-NS3 for 30 min in the presence of different concentrations of GuHCl in the absence of NTP. The hybridization of
the two strands was detected by gel electrophoresis and scanning on a Typhoon 9500 imager. The preannealed (lane 1) or boiled (lane 2) reaction
mixture was used as a positive or negative control, respectively. The hybridized and free strands are indicated. (E) The effect of GuHCl or 2CMC
on Norwalk virus RNA levels was determined by examining the impact on NV replicon RNA levels in HGT-NV cells following 3 days of treatment.
HGT-NV cells were treated with the indicated levels of either GuHCl or 2CMC, and the levels of viral RNA were calculated as a percentage of the
mock-treated control. *, P  0.05; **, P  0.01; ***, P  0.001. (F) HGT-NV cells were treated as for panel D, and the number of viable cells was
determined. The cell viability was calculated as a percentage of that of the mock-treated control. The error bars represent SD (n  3). Statistical
signiﬁcance was determined using an unpaired t test. The experiment was repeated at least two independent times, with one representative data
set presented.
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activities of NV NS3 are moderate but similar to the observed effects on EV71 2CATPase
(22). Nevertheless, these data demonstrate that GuHCl is an inhibitor of the key
biochemical activities of NV NS3.
GuHCl inhibits NV replication in cultured human cells. While we had shown that
GuHCl can inhibit the NTPase and helix-unwinding activities of NV NS3, we sought to
determine whether GuHCl treatment could inhibit HuNoV replication in cells. To this end,
the effect of GuHCl on HuNoV replication was evaluated by using the NV replicon system
in cultured human gastric tumor (HGT-1) cells. The levels of NV RNA in the presence of
GuHCl at different concentrations were determined by real-time quantitative reverse
transcription-PCR (qRT-PCR), and the expression levels of NV proteins were determined by
Western blotting of NV NS3. 2=-C-Methylcytidine (2CMC), a nucleoside analog that has been
reported to inhibit HuNoV replication (48, 49), was used as the positive control. As shown
in Fig. 9E, the presence of 1.125 mM GuHCl signiﬁcantly reduced the level of NV RNA to
around 50% of that under mock treatment, while increasing the GuHCl concentration to
3.25 mM only moderately enhanced the inhibitory effect of GuHCl on NV RNA replication.
As expected, 2CMC showed a strong inhibitory effect on NV RNA replication (Fig. 9E). We
also showed that the presence of 1.125 or 3.25 mM GuHCl did not affect the viability of
HGT-1 cells, as was found for 2CMC-treated cells, excluding the possibility that the inhib-
itory effect of GuHCl on NV RNA replication was due to inducing cell death (Fig. 9F). Hence,
GuHCl can inhibit the replication of the NV replicon at 1.125 mM in cultured human cells
without apparent cytotoxicity.
DISCUSSION
During the life cycle of RNA viruses, cellular or virus-encoded RNA helicases or
chaperones are believed to facilitate correct folding or unfolding of RNA structures or
to separate vRI-dsRNAs for more rounds of vRNA replication (14, 15, 22). Here, we report
for the ﬁrst time that NV-encoded NS3 has both NTP-dependent RNA helicase and
NTP-independent RNA-chaperoning activities that can unwind RNA helices and desta-
bilize and remodel structured RNA molecules. Moreover, we found that NS3 can
stimulate NS7/RdRP-mediated noroviral RNA synthesis in vitro, suggesting that NS3
plays an important role in norovirus RNA replication. Our work has also shown that
GuHCl, an FDA-approved small-molecule drug, can inhibit the RNA helicase activity of
NS3 in vitro and, more importantly, that this small molecule has some inhibitory activity
against replication of a HuNoV replicon in cultured human cells.
The RNA-remodeling activities of viral proteins are generally believed to play
important roles in viral life cycles (50). For instance, during vRNA replication of RNA
viruses, vRI-dsRNAs must be efﬁciently unwound, thereby releasing nascently synthe-
sized progeny vRNAs from vRNA templates. Moreover, viral genomic and antigenomic
RNAs contain multiple cis-acting elements, highly structured RNA regions that usually
play pivotal roles in the replication, translation, and encapsidation of vRNAs (11, 51).
Sometimes, a speciﬁc RNA structure required for one vRNA function, like translation or
encapsidation, may need disruption and refolding to facilitate another vRNA function,
like vRNA replication, and vice versa. For example, genomic RNAs or mRNAs of some
RNA viruses, including norovirus (13, 52, 53), ﬂavivirus (12), hantavirus (54), and reovirus
(55), can undergo circularization, resulting in the base pairing of vRNA 5= and 3= ends
to form panhandle-like structures that may facilitate vRNA translation, encapsidation, or
RdRP recruitment to the 3= ends of vRNAs (51, 56). However, for initiation of RNA
replication, these cyclized vRNA structures need to be disrupted to make the 3= ends
of the vRNAs accessible by RdRPs; an example of this type of activity is the chaperoning
effect of cypovirus VP5 on cyclized cypoviral mRNAs (25). Viral RNA-remodeling pro-
teins may also dynamically facilitate proper folding and unfolding of different vRNA
structures, thereby allowing vRNAs to switch among distinct functionalities.
For noroviruses, it has been found that their vRNAs contain multiple cis-acting
elements and RNA secondary structures, which are important for norovirus replication
(13, 51–53). With that in mind, it is intriguing that we have observed the ability of NS3
to enhance NS7/RdRP-mediated noroviral RNA synthesis in vitro, particularly since
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norovirus NS3 has recently been found to associate with vRI-dsRNAs in vRC on
intracellular membranes (34–36). These ﬁndings indicate the critical roles of NS3
in norovirus RNA replication. However, owing to technical limitations, the RNA-
remodeling activities of viral proteins have been mainly studied in vitro, and it is difﬁcult
to imagine how the regulation of the structures and functions of vRNAs by viral RNA
helicases/chaperones can be investigated in detail in virus-infected cells. Future ad-
vances in techniques may overcome these barriers and help us understand the mech-
anism(s) through which the RNA helicase/chaperoning activities of NS3 remodel vRNAs
at different stages of the noroviral life cycle.
Interestingly, we found that the guanidine salt GuHCl inhibits both the ATPase and
RNA helix-unwinding activities of NV NS3 in a dose-dependent manner (Fig. 9), similar
to the effects of the same compound on enterovirus 2CATPase (22, 41). Although
previous work found that the ATPase activity of SHV NS3 was not inhibited by GuHCl
(33), our data show some differences between NV NS3 and SHV NS3 in terms of ATPase
activity. For example, while SHV NS3 has been found to hydrolyze UTP much less well
than ATP (30), NV NS3 exhibited similar hydrolysis efﬁciencies for both ATP and UTP
(Fig. 2A). Moreover, when the concentration of Mg2 was higher than 2 mM, the
ATPase activity of NV NS3 was inhibited in a dose-dependent manner (Fig. 2C), while
that of SHV NS3 was moderately enhanced (30). It is possible that the difference
between NV NS3 and SHV NS3 in ATPase activity is due to the different (eukaryotic
versus prokaryotic) expression strategies.
Virus-encoded RNA-remodeling proteins, particularly helicases, have long been
considered valuable targets for antiviral compounds, because they are well conserved
within or even across virus families (57). In particular, enterovirus 2CATPase, another SF3
viral RNA helicase, has been found to be inhibited by 1 mM GuHCl, as is enterovirus
replication (22, 42–45). Using an NV replicon as a model, our studies demonstrated that
1 mM GuHCl can signiﬁcantly inhibit the replication of HuNoV in cultured human cells
with negligible cell toxicity (Fig. 9). Similarly, GuHCl can inhibit the replication of
poliovirus at the same concentration (22). Guanidines are ubiquitously present in
nature and are categorized as organic superbases with highly basic nature and notable
stability that can function as mediators of speciﬁc noncovalent binding in various
catalytic processes (58, 59). Due to their physicochemical characteristics, guanidine
molecules probably bind stably to the surfaces of viral RNA-remodeling proteins, such
as enterovirus 2CATPase and HuNoV NS3, and may therefore alter their conformations,
electrostatic states, and/or protein-protein/RNA interactions, thereby inhibiting their
RNA-remodeling activities. In accordance with this idea, high concentrations of Mg2
(2 mM) have been found to inhibit helix unwinding by either NV NS3 (Fig. 2C) or EV71
2CATPase (22). GuHCl is a U.S. FDA-approved small compound drug that has been used
to treat the symptoms of muscle weakness and fatigability associated with Eaton-
Lambert syndrome (60, 61; http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
?eventoverview.process&ApplNo001546). Moreover, guanidine derivatives have at-
tracted widespread interest for developing drugs against various diseases, and some of
them have been found to be potential antivirals against hepatitis C virus (HCV), human
immunodeﬁciency virus (HIV), and ﬂaviviruses (21, 58, 59). It is unlikely that GuHCl can be
directly used as an antiviral drug against HuNoV infection due to the high concentration
needed for inhibition of NS3 and NV replication. However, given the presence of multiple
derivative forms of guanidine, the synthesis and screening of various guanidine derivatives
and guanidine-containing compounds may help in the quest for small molecules that have
better inhibitory effects on HuNoV NS3 and HuNoV replication.
In conclusion, this study provides the ﬁrst demonstration of the RNA helicase and
chaperoning activities associated with a norovirus- or calicivirus-encoded protein and
reveals that NS3 may have a direct function (in concert with NS7/RdRP) in norovirus
RNA replication. Moreover, it also provides evidence that GuHCl is an inhibitor of not
only the in vitro RNA-remodeling activities of NS3, but also the replication of HuNoV in
human cells. Altogether, these ﬁndings highlight the functional signiﬁcance of NS3 in
the noroviral life cycle and shed new light on norovirus replication.
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MATERIALS AND METHODS
Construction of recombinant baculoviruses and expression and puriﬁcation of recombinant
proteins. The generation of pFastBac HTB-MBP has been described previously (26). The cDNA of NV NS3
(GenBank accession no. KF039736) was synthesized by Tian Yi Hui Yuan Biotech Co. (Wuhan, China) and
cloned into the vector pFastBac HTB-MBP. Site-directed mutagenesis was conducted as previously
described (26). The resulting plasmids were subjected to the Bac-to-Bac baculovirus system to produce
recombinant proteins. The primers used for NS3 plasmid construction were as follows: forward, GAATT
CATGGGCCCCGAGGACCTTGCCAGGGATCTCGTG (EcoRI), and reverse, GTCGACCTACTGGAGTTGGAACTCA
TCCTGTCTCTCCAT (SalI); the primers for GK168AA and GK168AA-DD212AA of NS3 were as follows:
forward, TGTGGGCCCCCTGGTATAGCTGCTACCAAG, and reverse, GTTCTGCTGCCTTGGTAGCAGCTATAC
CAG; forward, GCTGTGGGCTGCTTATGGAATGACAAAGAT, and reverse, TGTATCTTTGTCATTCCATAAGCAG
CCCAC. Underlined letters indicate restriction endonuclease sites, and the types of the restriction
endonucleases are shown in parentheses.
The expression and puriﬁcation of recombinant MBP alone and MBP fusion proteins were conducted
using standard procedures, as previously described (25, 26). All puriﬁed proteins were quantiﬁed with a
bicinchoninic acid (BCA) protein assay kit (CWBIO, China) and stored at 80°C in aliquots. Proteins were
separated on 10% SDS-PAGE and visualized with Coomassie blue.
Structural modeling and structural alignment analyses. The 3D structure of NV NS3 was modeled
by submitting its amino acid sequence to the HMMSTR/Rosetta server (ROBETTA, University of Wash-
ington [http://robetta.bakerlab.org/]). Five models were obtained, and the best one was chosen as a
template based on its score and assessed by submitting it to the SWISS-MODEL server (Swiss Institute of
Bioinformatics and Biozentrum, University of Basel, Basel, Switzerland [http://swissmodel.expasy.org]).
The ﬁgures showing the modeled NS3ΔN and the structural alignments with SV40 LTag (Protein Data
Bank [PDB] ID 4GDF), HPV18 E1 (PDB ID 1TUE), and AAV2 Rep40 (PDB ID 1U0J) were generated from
coordinate ﬁles using PyMOL version 1.1 (DeLano Scientiﬁc LLC, Southern San Francisco, CA).
NTPase assay. NTPase activities were determined by measuring the inorganic phosphate released
during NTP hydrolysis using a direct colorimetric assay according to our standard procedures as
previously described (26). The concentrations of released inorganic phosphate were determined by
matching the A620 in a known inorganic phosphate curve. All of the results given by this quantitative
assay were averages of three independently repeated experiments.
Preparation of oligonucleotide helix substrates. The nucleic acid helix substrates were prepared
according to our standard procedures as previously described (22). In brief, RNA, DNA, or RNA-DNA
hybrid helix substrates were prepared by annealing two complementary nucleic acid strands, one
strand of which was labeled at the 5= end with HEX while the other was unlabeled. The two strands
were mixed at a 1:1 ratio in a 10-l reaction mixture containing 25 mM HEPES-KOH (pH 8.0) and 25
mM NaCl, and the mixture was then heated to 95°C for 5 min and gradually cooled to 25°C to
produce helical duplexes. All the HEX-labeled DNA and RNA strands were purchased from TaKaRa
(Dalian, China), unlabeled DNA strands were synthesized by Invitrogen, and unlabeled RNA strands
were in vitro transcribed using T7 RNA polymerase (Promega, Madison, WI). The in vitro-transcribed
RNA strands were puriﬁed with a Poly-Gel RNA extraction kit (Omega Bio-Tek, Guangzhou, China)
according to the manufacturer’s instructions. The standard RNA helix substrate with both 5= and 3=
protrusions was annealed using RNA1 and RNA2, the DNA helix substrate was annealed using DNA2
and DNA3, the RNA*-DNA hybrid was annealed using RNA1 and DNA1, the DNA*-RNA hybrid was
annealed using DNA1 and RNA3, the 3= protruded RNA helix was annealed using RNA1 and RNA4,
and the 5= protruded RNA helix was annealed using RNA1 and RNA5. All the oligonucleotides used
in this study are listed in Table 1.
Helix-unwinding and RNA strand hybridization assays. Helix-unwinding assays were performed
according to our standard procedures as previously described (25). The reaction mixtures were electro-
phoresed on 15% native PAGE gels and then scanned with a Typhoon 9500 imager (GE Healthcare,
Piscataway, NJ).
The RNA hybridization assay was carried out according to our standard procedures as previously
described (25). In brief, the indicated amount of protein, 0.2 pmol HEX-labeled stem-loop-structured RNA
strand, and 0.2 pmol unlabeled stem-loop-structured RNA strand were added to reaction buffer and
incubated for 1 h or the indicated time. The sequences of the stem-loop-structured RNA strands are given
in Fig. 7B. The reaction products were resolved on 15% native PAGE gels, followed by scanning with a
Typhoon 9500 imager (GE Healthcare, Piscataway, NJ).
In vitro RdRP assays. The vRNA template was in vitro transcribed by T7 RNA polymerase as
described above. The ()-vRNA template contained 1 to 400 nt of 3=-end HuNoV ()-RNA, which is
complementary to the 5=-end 400 nt of HuNoV ()-RNA. The transcribed product was puriﬁed with a
Poly-Gel RNA extraction kit (Omega Bio-Tek, Guangzhou, China) according to the manufacturer’s
instructions. The cDNA of HuNoV NS7/RdRP (GenBank accession no. KR904238) was ampliﬁed by PCR
from full-length GII.4-Sydney HuNoV cDNA, which was generously provided by Linqing Zhao (Capital
Institute of Pediatrics, Beijing, China), and cloned into the vector pMAl-c2X-MBP (primers: forward,
GGATCCATGGGAGGAAACACTGTCATATGTGCCACCCAG, and reverse, GTCGACTCACTCGACGCCATCTTCAT
TCACAAAACTGGG). The recombinant MBP fusion with NS7/RdRP was puriﬁed as described above. The
RdRP assay was performed as previously described with minor modiﬁcations. In brief, the indicated
amounts of MBP-NS3 were included in 10-l reaction mixtures containing 50 mM HEPES-KOH (pH 7.5),
12.5 mM KCl, 5 mM MgCl2, 5 mM dithiothreitol (DTT), 20 U RNasin (Promega), and 5 mM NTPs. MBP-NS3
was included in the reaction mixture with or without 10 pmol NS7/RdRP at 30°C for the indicated time.
After that, the reaction was terminated with 2 loading buffer (20% 10 MOPS [morpholinepropane-
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sulfonic acid] running buffer, 10% glycerol, 50% formamide, 20% formaldehyde, and 0.05% bromophenol
blue) and then denatured at 65°C for 10 min. The samples were electrophoresed on 1.5% agarose-
formaldehyde denaturing gels and transferred onto N nylon membranes (Roche). The RdRP products
were detected via Northern blots that were performed according to our standard procedures (62). The
probe for the Northern blots is listed in Table 1.
Assessment of GuHCl treatment in HuNoV replicon-harboring cells. A baby hamster kidney cell
line harboring the NV replicon, provided by Kim Green (National Institutes of Health, Bethesda, MD), was
used as a source of viral VPg-linked RNA (63). Total RNA was isolated from the BHK-NV replicon-
containing cell line and transfected into HGT-1 cells (64). The transfected cells were placed under
selection using 1 mg/ml of G418, and clonal populations were generated by limiting dilution. The levels
of viral RNA were determined by qRT-PCR as described above, and a single clone, referred to as HGT-NV,
was selected for future use.
To examine the effect of GuHCl on NV replication, HGT-NV cells were seeded in a 96-well plate at
1,000 cells per well without G418. The HGT-NV cells were immediately incubated with media containing
various levels of GuHCl or 2CMC as a control. The cells were incubated at 37°C in 5% CO2 for 3 days. The
effect of GuHCl treatment on HuNoV replicon RNA was then evaluated by qRT-PCR as described
previously (65) and by Western blotting using rabbit polyclonal antisera to norovirus NS3. In addition, the
effect of GuHCl on cell viability was determined using CellTiter-Blue (Promega) according to the
manufacturer’s instructions.
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